NexgenRx Inc.
NXG.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,124.09% | 285.90% | 182.73% | 90.51% | 69.00% |
| Total Depreciation and Amortization | 7.61% | 12.09% | -82.53% | -81.39% | -80.68% |
| Total Amortization of Deferred Charges | -9.14% | -9.14% | -- | -- | -- |
| Total Other Non-Cash Items | 465.63% | 447.93% | -69.49% | -70.48% | -72.63% |
| Change in Net Operating Assets | -479.40% | -720.97% | 25.79% | 175.28% | 71.49% |
| Cash from Operations | 38.90% | -36.94% | 138.37% | 51.01% | 10.83% |
| Capital Expenditure | -9.20% | -8.90% | -125.88% | 64.23% | 78.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -126.59% | -172.86% | -22.19% | 20.66% | -539.92% |
| Cash from Investing | -92.00% | -122.02% | -482.20% | 46.81% | 33.49% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -39.95% | -29.17% | -25.13% | 2.51% | 44.90% |
| Issuance of Common Stock | -66.67% | 200.00% | 200.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 39.60% | 39.36% | -66.50% | 5.83% | -58.79% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 29.29% | 53.32% | -44.87% | 27.50% | -10.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 418.23% | -250.06% | -97.58% | 204.79% | 204.63% |